Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy <i>in vivo</i> and <i>in vitro</i>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy in vivo and in vitro

Published:2023-11-03 Issue: Volume: Page:1-10
ISSN:1381-3455
Container-title:Archives of Physiology and Biochemistry
language:en
Short-container-title:Archives of Physiology and Biochemistry

Author:

Liu Jufen¹,Wang Huijing²,Huang Cuiting³

Affiliation:

1. Ophthalmology Department of Shangyu People’s Hospital of Shaoxing City, Shaoxing, China

2. Health Management Center of Shangyu People’s Hospital of Shaoxing City, Shaoxing, China

3. Ophthalmology Department Of Ningde City Hospital, Ningde Normal University, China

Publisher

Informa UK Limited

Subject

Physiology (medical),Physiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13813455.2023.2274279

Reference39 articles.

1. HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression

2. TGF-β serum levels in diabetic retinopathy patients and the role of anti-VEGF therapy;Bonfiglio V.;International journal of molecular sciences,2020

3. Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages

4. Diabetic retinopathy

5. Exendin-4 Protects Human Retinal Pigment Epithelial Cells from H₂O₂-Induced Oxidative Damage via Activation of NRF2 Signaling

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP